CERTAINTY at the EBMT's 50th annual meeting in Glasgow

The 50th annual EBMT meeting included a feature on the CERTAINTY project, which showcased its innovative approach to the cellular immunotherapy virtual twin for personalised cancer treatment. The presentation, led by CERTAINTY coordinator Dr. Kristin Reiche, took place on 15 April 2024 during the session "CTD3 Cell Therapy Day 3 | Developing new technologies in cell and gene therapy." Additionally, a poster detailing the project was displayed. 

Held in Glasgow, the EBMT meeting was accessible both in-person and via live-stream, with sessions available on-demand for two months afterwards on the congress's virtual platform. The programme was diverse, covering topics from paediatrics to patient advocacy, highlighting the multidisciplinary approach of the meeting.